Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 346

1.

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Russano de Paiva Silva G, Tournier E, Sarian LO, Bulai-Livideanu C, Delsol G, Lamant L, Vassallo J, Brousset P, Laurent C.

Medicine (Baltimore). 2018 May;97(21):e10642. doi: 10.1097/MD.0000000000010642.

2.

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadié M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Brière J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roué I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P.

J Clin Oncol. 2017 Jun 20;35(18):2008-2017. doi: 10.1200/JCO.2016.71.2083. Epub 2017 May 1.

PMID:
28459613
3.

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, Traverse-Glehen A, Rousset T, Quintin-Roue I, Petrella T, Emile JF, Amara N, Rochaix P, Chenard-Neu MP, Tasei AM, Menet E, Chomarat H, Costes V, Andrac-Meyer L, Michiels JF, Chassagne-Clement C, de Leval L, Brousset P, Delsol G, Lamant L.

Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.

4.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P.

Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4. No abstract available.

5.

Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children.

Pasqualini C, Minard-Colin V, Saada V, Lamant L, Delsol G, Patte C, Le Deley MC, Valteau-Couanet D, Brugières L.

Br J Haematol. 2014 Apr;165(1):117-125. doi: 10.1111/bjh.12728. Epub 2014 Jan 21.

PMID:
24666094
6.

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Bisig B, de Reyniès A, Bonnet C, Sujobert P, Rickman DS, Marafioti T, Delsol G, Lamant L, Gaulard P, de Leval L.

Haematologica. 2013 Aug;98(8):1250-8. doi: 10.3324/haematol.2012.081935. Epub 2013 May 28.

7.

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.

Sibon D, Fournier M, Brière J, Lamant L, Haioun C, Coiffier B, Bologna S, Morel P, Gabarre J, Hermine O, Sonet A, Gisselbrecht C, Delsol G, Gaulard P, Tilly H.

J Clin Oncol. 2012 Nov 10;30(32):3939-46. doi: 10.1200/JCO.2012.42.2345. Epub 2012 Oct 8.

PMID:
23045585
8.

Anaplastic lymphoma kinase as a therapeutic target.

Kruczynski A, Delsol G, Laurent C, Brousset P, Lamant L.

Expert Opin Ther Targets. 2012 Nov;16(11):1127-38. doi: 10.1517/14728222.2012.719498. Epub 2012 Sep 24. Review.

PMID:
22998583
9.

Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination.

Colomba A, Giuriato S, Dejean E, Thornber K, Delsol G, Tronchère H, Meggetto F, Payrastre B, Gaits-Iacovoni F.

Blood Cancer J. 2011 Jun;1(6):e21. doi: 10.1038/bcj.2011.19. Epub 2011 Jun 3.

10.

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Morschhauser F, Recher C, Milpied N, Gressin R, Salles G, Brice P, Vey N, Haioun C, Colombat P, Rossi JF, Deconinck E, Lazreg F, Bergougnoux L, Delsol G, Attal M.

Ann Oncol. 2012 Oct;23(10):2687-95. Epub 2012 Jul 5.

PMID:
22767588
11.

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

de Medina P, Paillasse MR, Segala G, Al Saati T, Boyes J, Delsol G, Allal C, Marsili S, Silvente-Poirot S, Poirot M.

Biochimie. 2013 Mar;95(3):482-8. doi: 10.1016/j.biochi.2012.06.001. Epub 2012 Jun 16.

PMID:
22709869
12.

ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.

Dejean E, Foisseau M, Lagarrigue F, Lamant L, Prade N, Marfak A, Delsol G, Giuriato S, Gaits-Iacovoni F, Meggetto F.

Blood. 2012 May 17;119(20):4698-707. doi: 10.1182/blood-2011-10-386011. Epub 2012 Mar 6.

13.

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.

Lamant L, McCarthy K, d'Amore E, Klapper W, Nakagawa A, Fraga M, Maldyk J, Simonitsch-Klupp I, Oschlies I, Delsol G, Mauguen A, Brugières L, Le Deley MC.

J Clin Oncol. 2011 Dec 10;29(35):4669-76. doi: 10.1200/JCO.2011.36.5411. Epub 2011 Nov 14.

PMID:
22084369
14.

Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns.

Laurent C, Lopez C, Desjobert C, Berrebi A, Damm-Welk C, Delsol G, Brousset P, Lamant L.

Leukemia. 2012 Jan;26(1):188-90. doi: 10.1038/leu.2011.209. Epub 2011 Aug 12. No abstract available.

PMID:
21836614
15.

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR, Al Saati T, Soulier J, Desjobert C, Lamant L, Prósper F, Felsher DW, Cavaillé J, Prats H, Delsol G, Giuriato S, Meggetto F.

Leukemia. 2011 Dec;25(12):1882-90. doi: 10.1038/leu.2011.168. Epub 2011 Jul 22.

PMID:
21778999
16.

[Impact of the pathology in modern medicine].

Brousset P, Delsol G.

Med Sci (Paris). 2011 Jun-Jul;27(6-7):651-5. doi: 10.1051/medsci/2011276018. Epub 2011 Jul 1. Review. French.

17.

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression.

Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A, Soulier J, Espinos E, Meggetto F, Cavaillé J, Delsol G, Lamant L.

Blood. 2011 Jun 16;117(24):6627-37. doi: 10.1182/blood-2010-09-301994. Epub 2011 Apr 6.

18.

HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas.

Bergalet J, Fawal M, Lopez C, Desjobert C, Lamant L, Delsol G, Morello D, Espinos E.

Mol Cancer Res. 2011 Apr;9(4):485-96. doi: 10.1158/1541-7786.MCR-10-0351. Epub 2011 Feb 22.

19.

Immunoexpression of Survivin in non-neoplastic lymphoid tissues and malignant lymphomas using a new monoclonal antibody reactive on paraffin sections.

Vassallo J, Al Saati T, Gascoyne RD, Welsh K, Reed JC, Brousset P, Delsol G.

J Hematop. 2010 Jan 30;3(1):3-9. doi: 10.1007/s12308-009-0054-8.

20.

[Molecular abnormalities in lymphomas].

Delsol G.

Bull Cancer. 2010 Nov;97(11):1347-64. doi: 10.1684/bdc.2010.1214. Review. French.

21.

Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion.

Lagarrigue F, Dupuis-Coronas S, Ramel D, Delsol G, Tronchère H, Payrastre B, Gaits-Iacovoni F.

Cancer Res. 2010 Sep 1;70(17):6978-87. doi: 10.1158/0008-5472.CAN-10-0861. Epub 2010 Aug 10.

22.

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.

Giuriato S, Foisseau M, Dejean E, Felsher DW, Al Saati T, Demur C, Ragab A, Kruczynski A, Schiff C, Delsol G, Meggetto F.

Blood. 2010 May 20;115(20):4061-70. doi: 10.1182/blood-2008-06-163386. Epub 2010 Mar 11.

23.

Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases.

Lamant L, Pileri S, Sabattini E, Brugières L, Jaffe ES, Delsol G.

Haematologica. 2010 Mar;95(3):449-55. doi: 10.3324/haematol.2009.015024. Epub 2009 Nov 30.

24.

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, Delsol G, Brousset P.

J Clin Oncol. 2009 Sep 1;27(25):4211-6. doi: 10.1200/JCO.2008.21.5020. Epub 2009 Jul 27. Erratum in: J Clin Oncol. 2010 Jan 1;28(1):182.

PMID:
19636007
25.

Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas.

Thornber K, Colomba A, Ceccato L, Delsol G, Payrastre B, Gaits-Iacovoni F.

Oncogene. 2009 Jul 23;28(29):2690-6. doi: 10.1038/onc.2009.125. Epub 2009 Jun 8.

PMID:
19503098
26.

Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.

Faumont N, Le Clorennec C, Teira P, Goormachtigh G, Coll J, Canitrot Y, Cazaux C, Hoffmann JS, Brousset P, Delsol G, Feuillard J, Meggetto F.

Cancer Res. 2009 Jun 15;69(12):5177-85. doi: 10.1158/0008-5472.CAN-08-2866. Epub 2009 Jun 2.

27.

Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase.

Kruczynski A, Mayer P, Marchand A, Vispé S, Fournier E, Annereau JP, Brel V, Barret JM, Delsol G, Imbert T, Fahy J, Bailly C.

Anticancer Drugs. 2009 Jun;20(5):364-72. doi: 10.1097/CAD.0b013e32832a2ed9.

PMID:
19322071
28.

STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cells.

Archambaud C, Sansoni A, Mingueneau M, Devilard E, Delsol G, Malissen B, Malissen M.

J Immunol. 2009 Mar 1;182(5):2680-9. doi: 10.4049/jimmunol.0803257.

29.

Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.

Faumont N, Chanut A, Benard A, Cogne N, Delsol G, Feuillard J, Meggetto F.

Haematologica. 2009 Mar;94(3):355-63. doi: 10.3324/haematol.13269. Epub 2009 Feb 11.

30.

[The 2008 WHO lymphoma classification].

Delsol G.

Ann Pathol. 2008 Nov;28 Spec No 1(1):S20-4. doi: 10.1016/j.annpat.2008.09.002. Epub 2008 Oct 15. French. No abstract available.

PMID:
18984289
31.

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.

Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D, Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P.

J Exp Med. 2008 Oct 27;205(11):2499-506. doi: 10.1084/jem.20080285. Epub 2008 Oct 20.

32.

ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.

Chan JK, Lamant L, Algar E, Delsol G, Tsang WY, Lee KC, Tiedemann K, Chow CW.

Blood. 2008 Oct 1;112(7):2965-8. doi: 10.1182/blood-2008-03-147017. Epub 2008 Jul 25.

33.

Elevated levels of PtdIns5P in NPM-ALK transformed cells: implication of PIKfyve.

Coronas S, Lagarrigue F, Ramel D, Chicanne G, Delsol G, Payrastre B, Tronchère H.

Biochem Biophys Res Commun. 2008 Jul 25;372(2):351-5. doi: 10.1016/j.bbrc.2008.05.062. Epub 2008 May 22.

PMID:
18501703
34.

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

Salaverria I, Beà S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman D, Gascoyne R, Ott G, Siebert R, Delsol G, Campo E.

Br J Haematol. 2008 Mar;140(5):516-26. doi: 10.1111/j.1365-2141.2007.06924.x.

PMID:
18275429
35.

A new mitotic-cell specific monoclonal antibody.

Cazales M, Quaranta M, Lobjois V, Jullien D, Al Saati T, Delsol G, Ducommun B.

Cell Cycle. 2008 Jan 15;7(2):267-8. Epub 2007 Nov 7. No abstract available.

PMID:
18256524
36.

Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma.

Laurent C, de Paiva GR, Ysebaert L, Laurent G, March M, Delsol G, Brousset P.

Am J Clin Pathol. 2007 Dec;128(6):974-80.

PMID:
18024323
37.

Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.

Colomba A, Courilleau D, Ramel D, Billadeau DD, Espinos E, Delsol G, Payrastre B, Gaits-Iacovoni F.

Oncogene. 2008 Apr 24;27(19):2728-36. Epub 2007 Nov 12.

PMID:
17998938
38.

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study.

Le Deley MC, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, Zimmermann M, Brugières L; European Intergroup for Childhood Non-Hodgkin Lymphoma.

Blood. 2008 Feb 1;111(3):1560-6. Epub 2007 Oct 23.

39.

Primary bone marrow T-cell anaplastic large cell lymphoma with triple M gradient.

Szomor A, Al Saati T, Delsol G, Kereskai L, Szijártó Z, Losonczy H.

Pathol Oncol Res. 2007;13(3):260-2. Epub 2007 Oct 7.

40.

Discovery of human immunodeficiency virus infection by immunohistochemistry on lymph node biopsies from patients with unexplained follicular hyperplasia.

de Paiva GR, Laurent C, Godel A, da Silva NA Jr, March M, Delsol G, Brousset P.

Am J Surg Pathol. 2007 Oct;31(10):1534-8.

PMID:
17895754
41.

Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.

Giuriato S, Faumont N, Bousquet E, Foisseau M, Bibonne A, Moreau M, Al Saati T, Felsher DW, Delsol G, Meggetto F.

Cancer Biol Ther. 2007 Aug;6(8):1318-23. Epub 2007 May 29.

PMID:
17660712
42.

CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.

Vassallo J, Bousquet M, Quelen C, Al Saati T, Delsol G, Brousset P.

J Clin Pathol. 2007 May;60(5):573-5.

43.

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

de Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G, Lamant L, Leroy K, Brière J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P.

Blood. 2007 Jun 1;109(11):4952-63. Epub 2007 Feb 6.

44.

TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.

Armstrong F, Lamant L, Hieblot C, Delsol G, Touriol C.

Eur J Cancer. 2007 Mar;43(4):640-6. Epub 2007 Feb 2.

PMID:
17276053
45.

A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, Dastugue N, Brousset P.

Blood. 2007 Apr 15;109(8):3417-23. Epub 2006 Dec 19.

46.

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.

Brüggemann M, White H, Gaulard P, Garcia-Sanz R, Gameiro P, Oeschger S, Jasani B, Ott M, Delsol G, Orfao A, Tiemann M, Herbst H, Langerak AW, Spaargaren M, Moreau E, Groenen PJ, Sambade C, Foroni L, Carter GI, Hummel M, Bastard C, Davi F, Delfau-Larue MH, Kneba M, van Dongen JJ, Beldjord K, Molina TJ.

Leukemia. 2007 Feb;21(2):215-21. Epub 2006 Dec 14.

PMID:
17170730
47.

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.

Lamant L, de Reyniès A, Duplantier MM, Rickman DS, Sabourdy F, Giuriato S, Brugières L, Gaulard P, Espinos E, Delsol G.

Blood. 2007 Mar 1;109(5):2156-64. Epub 2006 Oct 31.

49.

"In situ-like" mantle cell lymphoma: a report of two cases.

Richard P, Vassallo J, Valmary S, Missoury R, Delsol G, Brousset P.

J Clin Pathol. 2006 Sep;59(9):995-6.

50.

Serpin A1 is overexpressed in ALK+ anaplastic large cell lymphoma and its expression correlates with extranodal dissemination.

Duplantier MM, Lamant L, Sabourdy F, de Reynies A, Delsol G, Espinos E.

Leukemia. 2006 Oct;20(10):1848-54. Epub 2006 Aug 10.

PMID:
16900211

Supplemental Content

Loading ...
Support Center